3d Printed Medical Devices Market

Key Findings

M&A and Expansion – Prominent Strategies Adopted by 3D Printed Medical Devices Market Players

M&A and expansion carried out by the 3D printed medical devices manufacturers are aimed at enhancing their product portfolio, increasing service-specific offerings and strengthening market presence in 3D printed medical devices market.

• In June 2018, the University of California (UCSF) has partnered with INTAMSYS, a Chinese 3D printer manufacturer to introduce low-cost yet high-tech orthopaedic implants in 3D printed medical devices market.

• In August 2018, Stryker, a leading 3D printed medical devices market player announced a plan to acquire K2M, another 3D printed medical device manufacturer. The acquisition is aimed at strengthening their presence in the area of spinal implants in 3D printed medical devices market.

• In 2018, a merger of the rail business of Siemens and Alstom is expected to create new opportunities for 3D printing as both the companies are experimenting 3D printed medical devices marketplace.

• In September 2018, J&J acquired Emerging Implants Technologies GmbH (EIT), a private manufacturer of 3D-printed titanium interbody implants. J&J will use its international presence in 3D printed medical devices market to introduce EIT technologies to patients.

• In 2017, EOS and Eurocoating announced a partnership- aimed at enhancing global business networks in the area of 3D printed medical devices.

• In November 2017, EnvisionTEC announced the partnership of Abergower as its global reseller partner to expand Envision’s global footprints in 3D printed medical devices market.

FDA Guidelines – A Prime Checkpoint for 3D Printed Medical Devices Market Players

Compliance with FDA regulations presents both challenges as well as opportunities to the manufacturers in 3D printed medical devices market. Stringent regulations pose manufacturing challenges in terms of implementing clinically relevant parameters. However, amidst ongoing introduction of an ample number of medical technologies, FDA guidelines enable 3D printed medical devices manufacturers to easily navigate the time-consuming FDA approval process, in turn, mainstream the manufacturing of 3D printed medical devices.

Well-aware of these market dynamics, the 3D printed medical devices marketplace is marked by manufacturers seeking to receive FDA approvals. For instance, Centinel Spine, a spinal device development company has received FDA approval for marketing its 3D printed medical devices in June 2018. Another, 3D printed medical devices manufacturer, Captiva Spine received FDA clearance for its TirboLOX-C 3D Printed Titanium Cervical Cages, in 2018.

Manufacturers Face Challenges in Introducing New Materials in 3D Printed Medical Devices

3D printed medical devices manufacturers face challenges of cost-intensive investments where approval of new material to be incorporated in 3D implants remains a time-consuming. In addition, optimization of different parameters to incorporate new material in 3D printed medical devices requires challenging and costly machine hardware engineering. Further, establishing a stable logistics ecosystem for the new biocompatible material in healthcare application also presents challenges for 3D printed medical devices manufacturers. Aware of these challenges, 3D printed medical devices market players are establishing a library of biocompatible materials to streamline the implant processes for partners and customers of 3D printed medical devices.

3D Printed Orthopedic Implant’s Adoption on the Rise amidst Increasing Prevalence of Osteoarthritis

Demand for orthopaedic implants in the 3D printed medical devices market is on the rise owing to increasing number of hip, knee and other joint replacement procedures. Ageing population is primarily responsible for the increasing numbers of hip, knee and other joint replacement surgeries. Amidst increasing prevalence of osteoarthritis and alike musculoskeletal conditions, 3D printed orthopaedic implant surgeries have witnessed a considerable rate of successful patient outcomes, thereby driving the adoption of 3D printed orthopaedic implants in 3D printed medical devices market.

3D Printed Medical Devices Market Stakeholders Make Hefty Investments in Bioprinting to Explore New Avenues of Organ Transplantation

Significant investments have been made in the field of bioprinting where living cells or biomaterials are used to generate 3D tissues which are, in turn, used in regenerative medicine or tissue engineering. In a bid to develop 3D printed organs for transplantation, multiple studies are underway to develop functional whole organs. While the studies and animal trials are in pipeline, a considerable success is reported in the area of skin and bones. Start-ups as well as prominent market players in the 3D printed medical devices market have made substantial investments in the field of bioprinting to explore the possibilities in the field of organ transplantation.

3D Printed Medical Devices Market: Competitive Landscape

3D printed medical devices market report has profiled few of the key 3d printed medical devices market players including 3D Systems, Inc., Arcam AB, Stratasys Ltd., EnvisionTEC, Cyfuse Biomedical K.K., Formlabs, Inc., FabRx Ltd. and EOS GmbH Electro Optical Systems among others.

3D printed medical devices market players are actively engaged in strategies such as mergers, acquisitions and collaborations. For instance, in January 2018, Stryker announced a distribution partnership with 3D Systems for VSP (Virtual Surgical Planning) and anatomical models for the craniomaxillofacial speciality.

EOS, a leader in 3D printed medical devices market expanded its production capacity by relocating its system manufacturing facilities to Maisach-Gerlinden.

Stratasys Ltd. another player in 3D printed medical devices market unveiled BioMimics range of a highly advanced 3D printed medical device models that allow accurate presentation of complex human anatomies.